Deerfield Management Company

About The Fund

Deerfield Management Company is an investment management firm dedicated to advancing healthcare through investment, information, and philanthropy. With a long-term perspective and operational and development expertise, Deerfield aims to connect capital, ideas, and technology in bold and collaborative ways to create real impact in the healthcare industry. Deerfield operates across the healthcare ecosystem, working on bridging academic research, early-stage innovation, and patient care. The firm's strategic alliances often involve substantial financial commitments, operational and managerial support to translational research and early-stage therapeutic ventures, with the goal of bringing innovations to the market that can vastly improve healthcare outcomes for individuals across the globe. One such initiative includes Deerfield's partnership with Harvard University, where through the company Lab1636, Deerfield committed $100 million to support the development and translation of biomedical and life-science innovations into potential new treatments. Deerfield is known for its flexible approach to financing, including providing support for various stages of drug discovery and development, which may include studies to explicate the biology of disease and validate therapeutic targets required for filing Investigational New Drug applications. Collaborations often result in co-funding projects along with renowned academic institutions and facilitating licensure to external companies. Through these alliances, Deerfield helps to accelerate the commercialization process of therapeutics developed in academic settings, creating bridge mechanisms for projects to move towards clinical validation. Their engagement not only provides translational research funding but also extends to support startup companies deriving from academic research, thus promoting entrepreneurship in the life science sector.